Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of the Efficacy of Entecavir in Patients With Chronic Hepatitis B Virus Infection and Persistently Normal Alanine Aminotransferase

NCT01833611 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.

NCT NCT01833611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01833611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of the Efficacy of Entecavir in Patients With Chronic Hepatitis B Virus Infection and Persistently Normal Alanine Aminotransferase
Lead sponsor
National Cheng-Kung University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2008
Completion date
May 31, 2015
Enrollment
130 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis